Get the SPI Wire

Lakewood-Amedex Biotherapeutics Inc.

NASDAQ:LABT
Annual Meeting

of Shareholders

MEETING DATE

09/22/2026
DEF 14A FILED
08/10/2026
PUBLISHED
08/10/2026 9:13 pm
TIME TO PUBLISH
08/12/2026
METHODOLOGY
approve
EXCHANGE NASDAQ:LABT · CUSIP · CLASS common stock, par value $0.0001 per share · CIK 0002079272

RECONCILED · MIXED

Reconciled against the company’s Form 8-K Item 5.07 filed 2026-06-15.

3
FOR
2
AGAINST
0
WITHHOLD
5
BALLOT ITEMS

ITEM-BY-ITEM RECOMMENDATIONS

1
To elect four directors to serve until the next annual meeting of stockholders for a term of one year and until their respective successors are duly elected and qualified
board
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The filing states four nominees are standing for election and have consented to serve if elected.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
2
To approve an amendment to our articles of incorporation, as amended (the “Articles of Incorporation”) to increase the number of authorized shares of our common stock, par value $0.0001 per share (the “Common Stock”) that we may issue from 12,500,000 shares to 100,000,000 shares
other
Elevated
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

Filing states additional authorized shares could make gaining control or removing management more difficult.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.
3
To approve a proposal to authorize the board of directors of the Company (the “Board”), in its sole and absolute discretion, and without further action of the stockholders, to file an amendment to our articles of incorporation, to effect one or more reverse stock splits of our issued and outstanding Common Stock at a ratio to be determined by the Board, and not to exceed a cumulative ratio of one-for-twenty (1:20), with such reverse stock splits to be effected at such time and date, if at all, as determined by the Board in its sole discretion, but no later than September 22, 2027, when the authority granted in this proposal to implement Reverse Stock splits would terminate
other
Elevated
Against
Board FOR · Duopoly unknown — ⚠ Divergence flagged

Filing states approval authorizes the Board to effect reverse stock splits without further stockholder action through September 22, 2027.

Divergence: 1 Review status: Approved. Publication ledger and 8-K reconciliation pending.
4
To approve an amendment to the Company’s 2020 Equity Incentive Plan, as amended, to increase the number of shares of the Company’s Common Stock issuable thereunder to 400,000 shares
compensation
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

As of July 30, 2026, 56,508 shares remained available for future awards under the 2020 Plan.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.
5
To ratify the appointment of CBIZ CPAs P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026
auditor
Elevated
For
Board FOR · Duopoly unknown — No divergence flagged

The Audit Committee determined non-audit services were compatible with maintaining the auditor's independence.

Divergence: 0 Review status: Approved. Publication ledger and 8-K reconciliation pending.

Ledger

c77cb9aa8ca244da9cbb901f116d629e76cde7bca01111154a607da0f00ef00d

Search company, ticker, executive, director or issue

    The SPI Wire · Proxy Intelligence

    Get every ballot call, before the vote.

    FOR, AGAINST or WITHHOLD on each covered ballot item — published within 48 hours of the definitive proxy filing. Follow the companies you own, or take the full feed.




    Pick the companies you own — you’ll only hear from us on their ballots.

    The SPI Wire covers proxy ballots only — it has nothing to do with Signal Research investigations. Research and analysis for informational purposes; not legal, investment, or voting advice. Unsubscribe anytime.

    Submit Information








      Join Monitoring List




        Receive Research Updates